Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis. (2009). Reumatismo, 61(3), 182-186. https://doi.org/10.4081/reumatismo.2009.182